Fresenius Medical Care closes at $23.26 after gaining 2.87%

Yesterday at a glance: the kidney dialysis specialist went up to $23.26, gaining 2.87%.

Nevertheless, United States Core Retail Sales published yesterday at 12:30 UTC came out at -0.8%, falling short of the -0.3% projections and continuing its decline from the previous 0% figure. United States Retail Sales fell short of the -0.4% projections, with new data of -1%.

Meanwhile, United States CFTC S&P 500 speculative net positions released yesterday at 20:30 UTC with a figure of -307,600, while the previous figure was -321,500.

Trend analysis indicates that the Commodity Channel Index (CCI) indicator is above +100, meaning the market price is unusually high compared to the rolling average. According to momentum evaluation, according to technical analysis of Fresenius Medical Care's Relative Strength Index (RSI), the market is currently overbought. According to asset volatility analysis, Fresenius Medical Care's upper Bollinger Band® is at $23.49, this is a slight indication of a slowdown. Visual analysis of Fresenius Medical Care's chart shows that Fresenius Medical Care is 54 cents away from testing key resistance at $23.8. Peaking above this level could inspire market bulls and open the path to further gains.

Notwithstanding Fresenius Medical Care's appreciation in recent days, the technical outlook suggests its bullish run is now fading.

Fresenius Medical Care went up yesterday, yet these health care stocks did not follow — UnitedHealth went down to $511.79, losing 2.74% after it closed at $526.23 yesterday. Astrazeneca PLC decreases 1.22% yesterday to close at $74.77. Medtronic went down to $80.71, losing 1.08% after it closed at $81.59 yesterday.

The stock has been trending positively for about a month. The US-German healthcare company has managed to gain 46.25% so far this year despite trading at lows around $12.81 previously.